Your browser doesn't support javascript.
loading
Lung-Protective Ventilation for Pediatric Acute Respiratory Distress Syndrome: A Nonrandomized Controlled Trial.
Wong, Judith Ju Ming; Dang, Hongxing; Gan, Chin Seng; Phan, Phuc Huu; Kurosawa, Hiroshi; Aoki, Kazunori; Lee, Siew Wah; Ong, Jacqueline Soo May; Fan, Lijia; Tai, Chian Wern; Chuah, Soo Lin; Lee, Pei Chuen; Chor, Yek Kee; Ngu, Louise; Anantasit, Nattachai; Liu, Chunfeng; Xu, Wei; Wati, Dyah Kanya; Gede, Suparyatha Ida Bagus; Jayashree, Muralidharan; Liauw, Felix; Pon, Kah Min; Huang, Li; Chong, Jia Yueh; Zhu, Xuemei; Hon, Kam Lun Ellis; Leung, Karen Ka Yan; Samransamruajkit, Rujipat; Cheung, Yin Bun; Lee, Jan Hau.
Afiliação
  • Wong JJM; Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore.
  • Dang H; Duke-NUS Medical School, Singapore.
  • Gan CS; Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Phan PH; China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.
  • Kurosawa H; Department of Paediatrics, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
  • Aoki K; Vietnam National Children's Hospital, Hanoi, Vietnam.
  • Lee SW; Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.
  • Ong JSM; Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.
  • Fan L; Sultanah Aminah Hospital, Johor, Malaysia.
  • Tai CW; Hospital Tengku Ampuan Rahimah, Selangor, Malaysia.
  • Chuah SL; Division of Paediatric Critical Care, National University Hospital, Singapore.
  • Lee PC; Division of Paediatric Critical Care, National University Hospital, Singapore.
  • Chor YK; Universiti Kebangsaan Malaysia Specialist Children's Hospital, Kuala Lumpur, Malaysia.
  • Ngu L; Department of Paediatrics, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
  • Anantasit N; Universiti Kebangsaan Malaysia Specialist Children's Hospital, Kuala Lumpur, Malaysia.
  • Liu C; Sarawak General Hospital, Sarawak, Malaysia.
  • Xu W; Sarawak General Hospital, Sarawak, Malaysia.
  • Wati DK; Ramathibodi Hospital, Bangkok, Thailand.
  • Gede SIB; Shengjing Hospital of China Medical University, Liaoning, China.
  • Jayashree M; Shengjing Hospital of China Medical University, Liaoning, China.
  • Liauw F; Pediatric Emergency and Intensive Care Unit, Prof I.G.N.G Ngoerah Hospital, Bali, Indonesia.
  • Pon KM; Medical Faculty, Udayana University, Bali, Indonesia.
  • Huang L; Pediatric Emergency and Intensive Care Unit, Prof I.G.N.G Ngoerah Hospital, Bali, Indonesia.
  • Chong JY; Medical Faculty, Udayana University, Bali, Indonesia.
  • Zhu X; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Hon KLE; Harapan Kita National Women and Children Health Center, Jakarta, Indonesia.
  • Leung KKY; Penang General Hospital, Penang, Malaysia.
  • Samransamruajkit R; Guangzhou Women and Children's Medical Center, Guangdong, China.
  • Cheung YB; Hospital Tunku Azizah Kuala Lumpur, Kuala Lumpur, Malaysia.
  • Lee JH; Children's Hospital of Fudan University, Shanghai, China.
Crit Care Med ; 2024 Jun 26.
Article em En | MEDLINE | ID: mdl-38920618
ABSTRACT

OBJECTIVES:

Despite the recommendation for lung-protective mechanical ventilation (LPMV) in pediatric acute respiratory distress syndrome (PARDS), there is a lack of robust supporting data and variable adherence in clinical practice. This study evaluates the impact of an LPMV protocol vs. standard care and adherence to LPMV elements on mortality. We hypothesized that LPMV strategies deployed as a pragmatic protocol reduces mortality in PARDS.

DESIGN:

Multicenter prospective before-and-after comparison design study.

SETTING:

Twenty-one PICUs. PATIENTS Patients fulfilled the Pediatric Acute Lung Injury Consensus Conference 2015 definition of PARDS and were on invasive mechanical ventilation.

INTERVENTIONS:

The LPMV protocol included a limit on peak inspiratory pressure (PIP), delta/driving pressure (DP), tidal volume, positive end-expiratory pressure (PEEP) to Fio2 combinations of the low PEEP acute respiratory distress syndrome network table, permissive hypercarbia, and conservative oxygen targets. MEASUREMENTS AND MAIN

RESULTS:

There were 285 of 693 (41·1%) and 408 of 693 (58·9%) patients treated with and without the LPMV protocol, respectively. Median age and oxygenation index was 1.5 years (0.4-5.3 yr) and 10.9 years (7.0-18.6 yr), respectively. There was no difference in 60-day mortality between LPMV and non-LPMV protocol groups (65/285 [22.8%] vs. 115/406 [28.3%]; p = 0.104). However, total adherence score did improve in the LPMV compared to non-LPMV group (57.1 [40.0-66.7] vs. 47.6 [31.0-58.3]; p < 0·001). After adjusting for confounders, adherence to LPMV strategies (adjusted hazard ratio, 0.98; 95% CI, 0.97-0.99; p = 0.004) but not the LPMV protocol itself was associated with a reduced risk of 60-day mortality. Adherence to PIP, DP, and PEEP/Fio2 combinations were associated with reduced mortality.

CONCLUSIONS:

Adherence to LPMV elements over the first week of PARDS was associated with reduced mortality. Future work is needed to improve implementation of LPMV in order to improve adherence.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Crit Care Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Singapura

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Crit Care Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Singapura